MedX Health Corp. Appoints Veteran Healthcare Industry Executive Damon Goodwin as Global Director of Sales

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

MedX Health Corp. has announced the appointment of healthcare industry executive Damon Goodwin as Global Director of Sales, effective immediately. Mr. Goodwin will play an integral part in MedX’s revenue growth by building global partnerships for MedX’s skin assessment telemedicine technology. Initially supporting the roll out and expansions in Mexico, Brazil and the USA, he will also be responsible for securing joint ventures & partnerships around the world.

“Damon brings years of experience in scaling revenue and building partnerships, the skill sets required as MedX enters an accelerated growth phase, and we are confident he will be able to assist us in driving sales for this next stage of our rapid growth,” said Scott Spearn, CEO of MedX. With our recent funding completed, we now have the opportunity to aggressively pursue markets, both locally and around the world, and we are excited to have him on board as we strengthen our team.”

Mr. Goodwin’s career has spanned many years in the healthcare industry, including roles with pharmaceutical companies in business strategy, international product licensing, business development and operations. He has proven expertise in leading companies through start-up to rapid growth, expansion and value creation at companies such as Biovail, Organon, Boehringer Ingelheim and Aspen Pharmacare.

“This ground-breaking technology that allows Dermatologists to remotely triage potentially lethal lesions will not only help save lives, it can dramatically improve healthcare system capacity,” noted Mr. Goodwin. “It’s an exciting time to be involved and I’m thrilled to be in this new role.”

Currently, between two and three million non-melanoma skin cancers and 300,000 melanoma skin cancers occur globally each year. One in every three cancers diagnosed is a skin cancer and, according to Skin Cancer Foundation Statistics, one in every five people will develop skin cancer in their lifetime. The global demand for SIAscopy on DermSecure™ will continue to increase with the growth of telemedicine and as early detection is recognized as the way to optimize survival and reduce healthcare costs.



Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.